glp-1 reduce inflammation Drugs: For Multiple Chronic Conditions GLP-1 receptor agonists show evidence

369 HoldenSMaksoudREaton-FitchNCabanasHStainesDMarshall-GradisnikS

Supplementary information Figure slide (download PPTX (PPTX 252 kb) Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made

In the UK, GLP-1 receptor agonists are primarily prescribed for two main indications : type 2 diabetes mellitus and weight management in adults with obesity or overweight with weight-related comorbidities

Cell 25 , 18191823 (2014)

As far as secondary metabolism is concerned, phenylpropanoids, a class of compounds produced from the amino acid phenylalanine acting as signal molecules both in plant development and defense (Vittani et al